randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als A Multicenter, Randomized, Double-blind, Clinical Efficacy in Patients with Dementia Associated with Cerebrovascular Disease The Scientific and Therapeutic Rationale
The Scientific and Therapeutic Rationale for OffLabel Treatments in Amyotrophic Lateral Sclerosis Bedlack 2025 Annals of Neurology Wiley Online Library Randomised, double blind, placebo controlled, parallel group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with A multicenter, randomized, placebo controlled, double blind phase 3 trial with open arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome Kidney International Frontiers A randomized clinical trial to evaluate the efficacy of L carnitine L tartrate to modulate the effects of SARS CoV 2 infection A 1 year multicenter placebo controlled study of acetyl L carnitine in patients with Alzheimer's disease Neurology Full article: Randomized double blind placebo controlled trial of acetyl L carnitine for ALS
Pay in 4 interest-free payments of $6.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15





